Scorpion Therapeutics IPO

Scorpion Therapeutics is an oncology company focused on transforming cancer treatment through an approach that offers precise selectivity and efficacy for oncology patients. Scorpion Therapeutics was founded in 2020 and is headquartered in Boston, MA. The company uses its proprietary technology platform that integrates cancer biology, medicinal chemistry, and data sciences for a holistic approach. The platform aims to allow Scorpion Therapeutics to create highly selective small-molecule compounds that target a broad spectrum of cancer drivers.

Register for Details

For more details on financing and valuation for Scorpion Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Scorpion Therapeutics

Forge green plus iconForge green minus icon

Is Scorpion Therapeutics a publicly traded company?

Scorpion Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

Will Scorpion Therapeutics go IPO?

Scorpion Therapeutics has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

Forge green plus iconForge green minus icon

What is Scorpion Therapeutics's IPO price?

The IPO price for Scorpion Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Scorpion Therapeutics pre-IPO?

Scorpion Therapeutics is privately held company and is not publicly traded, therefor investing in Scorpion Therapeutics pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my Scorpion Therapeutics shares?

To determine the value of your Scorpion Therapeutics shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Scorpion Therapeutics shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell Scorpion Therapeutics before it goes public?

Yes, you can seek to sell shares in Scorpion Therapeutics while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is Scorpion Therapeutics's funding to date?

Scorpion Therapeutics has raised $420.47MM to date.
Forge green plus iconForge green minus icon

When was Scorpion Therapeutics founded?

Scorpion Therapeutics was founded in 2020.

Who are Scorpion Therapeutics's major investors?

Casdin Capital
Lightspeed Venture Partners
Wellington Management
Atlas Venture
Fidelity Management & Research
Frazier Healthcare Partners
Woodline Partners
Janus Henderson Investors
The Invus Group
Olive Tree Capital
EcoR1 Capital
Logos Capital
Boxer Capital
Nextech Invest
Surveyor Capital
Citadel Enterprise Americas
Vida Ventures (Boston)
Mass General Brigham Ventures
Omega Funds
Willett Advisors
Hillhouse Investment Group

Scorpion Therapeutics funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series C-1 and C-2

$150MM raised $XXX.XX $XXX.XX

Series B

$162MM raised $XXX.XX $XXX.XX

Series A-1 and A-2

$108.47MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jul 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.